ABSTRACT
Efficient oxygen utilization in the kidney may be supported by paracellular epithelial transport, a form of passive diffusion that is driven by preexisting transepithelial electrochemical gradients. Claudins are tight-junction transmembrane proteins that act as paracellular ion channels in epithelial cells. In the proximal tubule (PT) of the kidney, claudin-2 mediates paracellular sodium reabsorption. Here, we used murine models to investigate the role of claudin-2 in maintaining energy efficiency in the kidney. We found that claudin-2-null mice conserve sodium to the same extent as WT mice, even during profound dietary sodium depletion, as a result of the upregulation of transcellular Na-K-2Cl transport activity in the thick ascending limb of Henle. We hypothesized that shifting sodium transport to transcellular pathways would lead to increased whole-kidney oxygen consumption. Indeed, compared with control animals, oxygen consumption in the kidneys of claudin-2-null mice was markedly increased, resulting in medullary hypoxia. Furthermore, tubular injury in kidneys subjected to bilateral renal ischemia-reperfusion injury was more severe in the absence of claudin-2. Our results indicate that paracellular transport in the PT is required for efficient utilization of oxygen in the service of sodium transport. We speculate that paracellular permeability may have evolved as a general strategy in epithelial tissues to maximize energy efficiency.
Subject(s)
Claudin-2/metabolism , Gene Expression Regulation , Kidney/metabolism , Oxygen/metabolism , Sodium/metabolism , Animals , Diet , Epithelial Cells/metabolism , Female , Ion Transport , Kidney Tubules, Proximal/metabolism , Loop of Henle/metabolism , Magnesium/metabolism , Male , Malondialdehyde/urine , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxygen Consumption , Permeability , Reperfusion Injury/metabolism , Tight Junctions/metabolismABSTRACT
The Notch pathway is an evolutionarily conserved signaling cascade that is critical in kidney development and has also been shown to play a pathogenetic role in a variety of kidney diseases. We have previously shown that the Notch signaling pathway is activated in human immunodeficiency virus-associated nephropathy (HIVAN) as well as in a rat model of the disease. In this study, we examined Notch signaling in the well established Tg26 mouse model of HIVAN. Notch signaling components were distinctly upregulated in the kidneys of these mice as well as in immortalized podocytes derived from these mice. Notch1 and Notch4 were upregulated in the Tg26 glomeruli, and Notch4 was also expressed in tubules. Notch ligands Jagged1, Jagged2, Delta-like1, and Delta-like 4 were all upregulated in the tubules of Tg26 mice, but glomeruli showed minimal expression of Notch ligands. To examine a potential pathogenetic role for Notch in HIVAN, Tg26 mice were treated with GSIXX, a gamma secretase inhibitor that blocks Notch signaling. Strikingly, GSIXX treatment resulted in significant improvement in both histological kidney injury scores and renal function. GSIXX-treated Tg26 mice also showed diminished podocyte proliferation and dedifferentiation, cellular hallmarks of the disease. Moreover, GSIXX blocked podocyte proliferation in vitro induced by HIV proteins Nef and Tat. These studies suggest that Notch signaling can promote HIVAN progression and that Notch inhibition may be a viable treatment strategy for HIVAN.
Subject(s)
AIDS-Associated Nephropathy/metabolism , Podocytes/metabolism , Proto-Oncogene Proteins/metabolism , Receptor, Notch1/metabolism , Receptors, Notch/metabolism , Signal Transduction/physiology , AIDS-Associated Nephropathy/drug therapy , AIDS-Associated Nephropathy/pathology , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Animals , Cell Dedifferentiation/drug effects , Cell Dedifferentiation/physiology , Cell Division/drug effects , Cell Division/physiology , Cell Line, Transformed , Dibenzazepines/pharmacology , Dipeptides/pharmacology , Disease Models, Animal , Disease Progression , Humans , Kidney/drug effects , Kidney/pathology , Kidney/physiology , Ligands , Mice , Mice, Inbred Strains , Mice, Transgenic , Podocytes/cytology , Podocytes/drug effects , Proto-Oncogene Proteins/antagonists & inhibitors , Receptor, Notch1/antagonists & inhibitors , Receptor, Notch4 , Receptors, Notch/antagonists & inhibitors , Signal Transduction/drug effects , Up-Regulation/drug effects , Up-Regulation/physiologyABSTRACT
Polycystic kidney diseases (PKD) are inherited disorders characterized by fluid-filled cysts primarily in the kidneys. We previously reported differences between the expression of Cux1, p21, and p27 in the cpk and Pkd1 null mouse models of PKD. Embryonic lethality of Pkd1 null mice limits its study to early stages of kidney development. Therefore, we examined mice with a collecting duct specific deletion in the Pkd1 gene. Cux1 was ectopically expressed in the cyst lining epithelial cells of newborn, P7 and P15 Pkd1(CD) mice. Cux1 expression correlated with cell proliferation in early stages of cystogenesis, however, as the disease progressed, fewer cyst lining cells showed increased cell proliferation. Rather, Cux1 expression in late stage cystogenesis was associated with increased apoptosis. Taken together, our results suggest that increased Cux1 expression associated with apoptosis is a common feature of late stage cyst progression in both the cpk and Pkd1(CD) mouse models of PKD.